Product Information
BACITRACIN 500 UNIT/GM OINTMNT is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.1173 per GM under NDC 45802006001. Its NADAC has been published 671 times since Nov 28, 2013.
Strength
500 [USP'U]/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802006001
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BACITRACINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M004On Market Since
6/20/2011
Pharmacological Classes
Price Statistics
The NADAC for BACITRACIN 500 UNIT/GM OINTMNT has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 36.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1173 per GM |
|---|---|
| All-time high | $0.1198 (Apr 15, 2026) |
| All-time low | $0.0805 (Sep 23, 2015) |
| 52-week high | $0.1198 |
| 52-week low | $0.1052 |
| Median price | $0.0994 |
| Average price | $0.0996 |
| Largest weekly change | -24.5% (Apr 17, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 37% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bacitracin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BACITRACIN 500 UNIT/GM OINTMNT?
The current National Average Drug Acquisition Cost (NADAC) for BACITRACIN 500 UNIT/GM OINTMNT, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.1173 per GM (NDC 45802006001), effective Sep 30, 2026.
How has the price of BACITRACIN 500 UNIT/GM OINTMNT changed over time?
Over the history we have for it, the NADAC for BACITRACIN 500 UNIT/GM OINTMNT has risen 36.6%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BACITRACIN 500 UNIT/GM OINTMNT?
Since Nov 28, 2013, the NADAC for BACITRACIN 500 UNIT/GM OINTMNT has ranged from a low of $0.0805 (Sep 23, 2015) to a high of $0.1198 (Apr 15, 2026), with a median of $0.0994 per GM.
Are there cheaper alternatives to BACITRACIN 500 UNIT/GM OINTMNT?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BACITRACIN 500 UNIT/GM OINTMNT, is $0.0735 per GM — about 37% below BACITRACIN 500 UNIT/GM OINTMNT.
Who manufactures BACITRACIN 500 UNIT/GM OINTMNT?
BACITRACIN 500 UNIT/GM OINTMNT (NDC 45802006001) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.